Torrent Pharmaceuticals dissolves Philippines subsidiary Curatio Inc
Torrent Pharmaceuticals voluntarily dissolved its wholly owned Philippines-based subsidiary, Curatio Inc., on July 10, 2026. The subsidiary contributed nil turnover and had a net worth of Rs 1.3 Crores as of March 31, 2026. The company confirmed the dissolution on July 17, 2026, stating the move was executed via an amendment to the subsidiary's Articles of Incorporation.
*this image is generated using AI for illustrative purposes only.
Torrent Pharmaceuticals has voluntarily dissolved its wholly owned subsidiary, Curatio Inc., in the Philippines, effective July 10, 2026. The company received official communication regarding the dissolution on July 17, 2026. The subsidiary was domiciled in the Philippines and ceased operations through the shortening of its term of existence via an amendment to its Articles of Incorporation.
The disclosure was made to the stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The dissolution was not part of a slump sale, and no consideration was received as the entity was dissolved rather than sold.
Financial details of the subsidiary for the last financial year indicate minimal contribution to the parent company's overall operations. As of March 31, 2026, the unit had recorded nil turnover.
Financial Impact of Dissolution
The following table outlines the financial position of the subsidiary prior to its dissolution:
| Particulars | Details |
|---|---|
| Turnover for FY 2025-26 | Nil (0%) |
| Net worth for FY 2025-26 | Rs 1.3 Crores (0.02%) |
The dissolution does not involve any related party transactions or a sale outside a Scheme of Arrangement. Consequently, the closure is not expected to have a material financial impact on Torrent Pharmaceuticals, given the subsidiary's negligible revenue contribution.
Historical Stock Returns for Torrent Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.14% | +1.20% | +12.93% | +26.41% | +42.83% | +234.05% |
How will Torrent Pharmaceuticals reallocate the resources previously dedicated to the Philippine market?
Does this dissolution signal a broader strategic shift to exit non-performing or low-revenue international markets?
What are the tax implications or potential savings for Torrent Pharma following the closure of this subsidiary?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
